HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Steinaa, L. Articles by Gautam, A. M. Search for Related Content PubMed PubMed Citation Articles by Steinaa, L. Articles by Gautam, A. M.

Linked Foreign T-Cell Help Activates Self-Reactive CTL and Inhibits Tumor Growth¹

Lucilla Steinaa^*, Peter Birk Rasmussen^1,*, Anne Marie Wegener^*, Lene Sonderbye^*, Dana R. Leach^*, Jørgen Rygaard, Søren Mouritsen^* and Anand M. Gautam^2,*

^* Pharmexa, Hørsholm, Denmark; and The Bartholin Institute, The National Hospital, University of Copenhagen, Denmark

Transgenic mice expressing membrane-bound OVA under the rat insulin promoter, RIP-mOVA, has previously been suggested to display deletional tolerance toward the dominant CTL epitope, SIINFEKL, and provide an elegant model system to test the hypothesis that the lack of T cell help contributes to the tolerance. To understand how the CD8 tolerance is maintained in these mice, a set of neo-self-Ags, OVA, modified to contain a foreign Th peptide, were constructed and tested for their ability to induce CTL responses in RIP-mOVA mice. Immunization with these Th peptide-modified OVA molecules and not with the wild-type OVA induced self-reactive CTLs recognizing dominant CTL peptide, SIINFEKL. Importantly, immunization with the modified OVA constructs also prevented the growth of OVA-expressing tumors in transgenic mice. Since endogenous OVA Th peptides did not contribute toward breaking self CTL tolerance, these results also highlighted a very robust CD4 T cell tolerance toward OVA in RIP-mOVA mice that has not been previously described. These results therefore provide direct evidence that it is the tolerance in the CD4 Th cell compartment that helps maintain the CTL tolerance against self-Ag in these mice. Since the CTL tolerance can be broken or bypassed by foreign Th peptides inserted into a self Ag, potential of using this approach in generating effective therapeutic cancer vaccines is discussed.

This article has been cited by other articles:

				A. Hosoi, Y. Takeda, Y. Furuichi, M. Kurachi, K. Kimura, R. Maekawa, K. Takatsu, and K. Kakimi Memory Th1 Cells Augment Tumor-Specific CTL following Transcutaneous Peptide Immunization Cancer Res., May 15, 2008; 68(10): 3941 - 3949. [Abstract] [Full Text] [PDF]

				K. Kianizad, L. A. Marshall, N. Grinshtein, D. Bernard, R. Margl, S. Cheng, F. Beermann, Y. Wan, and J. Bramson Elevated Frequencies of Self-reactive CD8+ T Cells following Immunization with a Xenoantigen Are Due to the Presence of a Heteroclitic CD4+ T-Cell Helper Epitope Cancer Res., July 1, 2007; 67(13): 6459 - 6467. [Abstract] [Full Text] [PDF]